Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function

doi:10.12998/wjcc.v9.i28.8349

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3621)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-7) series.

Item

Count

PDF

293

WORD

120

HTML

2343

Tables (1-7)

223

Sum=2979

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

276

Download

363

Sum=639

Oct 6, 2021 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Oct 6, 2021; 9(28): 8349-8357
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8349

Table 7 Comparison of hormone levels between the two groups (n = 65)

Group	FSH (IU/L)		E2 (pg/mL)		AMH (ng/mL)
Group	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Fenmatong group	18.21 ± 2.44	13.78 ± 2.06	25.38 ± 3.24	44.23 ± 4.05	0.22 ± 0.05	0.26 ± 0.07
Observation group	18.14 ± 2.26	10.14 ± 1.57	24.89 ± 4.77	57.96 ± 5.17	0.21 ± 0.08	0.29 ± 0.09
t	0.170	11.330	0.685	16.855	0.855	2.121
P value	0.866	0.000	0.495	0.000	0.394	0.036

FSH: Follicle-stimulating hormone; E2: Estradiol; AMH: Anti-Mullerian hormone.

Citation: Lin XM, Chen M, Wang QL, Ye XM, Chen HF. Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function. World J Clin Cases 2021; 9(28): 8349-8357
URL: https://www.wjgnet.com/2307-8960/full/v9/i28/8349.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i28.8349